Category:

EXECUTIVES

Covalon Announces CFO Transition

Danny Brannagan, its Chief Financial Officer, will be stepping down in January 2022 to pursue other endeavors.

illumiSonics Appoints Jochen Schweizer as COO

"Mr. Schweizer's rich commercialization history in micro-surgery, sales, product management, and software development will add significant depth to the team as we enable cancer surgeons and pathologists to get direct to digital pathology during surgery, preventing second surgeries due to positive surgical margins," said Rocky Ganske CEO.

Jim Beiermann Appointed Sr. Executive Officer of Southwestern Health Resources

“SWHR is paving the way in creating a healthcare model based on value,” said Beiermann, “And value can be achieved by providing quality care, improving clinical outcomes and delivering a great patient experience. When we do this and do what’s right for the patient, we can effectively lower the overall cost of delivering that exceptional care.”

GEDSA Announces New Executive Director following Retirement of Previous Director

Executive Director, Michael K. Cusack announced his retirement from the nonprofit on December 3, 2021.

PrecisionOS Appoints Six Prominent Shoulder and Elbow Orthopedic Surgeons to Clinical Advisory Board

The six surgeons are all highly-respected in the orthopedic community and have either served, or are currently serving, on numerous prestigious organization boards and committees. All six have published extensively, as well as lectured to national and international audiences on their respective areas of expertise while being educators to hundreds of residents and fellows.

Philips Provides Update on Composition of its Supervisory Board

Herna Verhagen and Sanjay Poonen proposed as new members of Philips’ Supervisory Board. Paul Stoffels and Marc Harrison proposed for re-appointment as members of the Supervisory Board and Neelam Dhawan to retire from the Supervisory Board after the third consecutive term.

George Adams MD Named CMO of Cordis

Dr. Adams comes to Cordis with a distinguished combination of clinical practice, medical research, and product development experience. He is globally recognized for his expertise in the treatment of peripheral vascular disease in patients with critical limb ischemia and the treatment of coronary artery disease in patients with acute coronary syndromes.

CATO SMS Appoints Marcus S. Delatte PhD VP of Nonclinical Regulatory Strategy

Dr. Delatte joins CATO SMS from Parexel International where he held the role as vice president of technical and as a principal consultant.

Premia Spine Appoints Three New Board Advisors

Advisors bring decades of clinical, business and medical device innovation experience to the company.
Medical Device News Magazinespot_img